Mycoplasma hominis: What a Positive Test Means

*Mycoplasma hominis* can live in the genital and urinary tracts without causing disease. This state is called carriage or colonization.

A positive test shows that the organism was detected in the tested sample. It does not automatically mean that the organism caused an infection.

Carriage without symptoms is common. Most people with carriage do not get sick. The result must be read alongside symptoms, sample type, and other test results.

The 2018 European STI Guidelines Editorial Board advises against routine testing in nonpregnant adults. This advice applies to adults with symptoms and those without symptoms.

The guidance also advises against routine treatment based only on detection. Unneeded treatment can increase costs and promote antibiotic resistance.

This article explains what the result may mean. It also covers testing, treatment, evidence limits, and special health concerns.

*Mycoplasma hominis* is a very small type of bacterium ^2,5. It can live on the lining of the genital and urinary tracts.

It belongs to a group called Mollicutes. Unlike many bacteria, members of this group have no cell wall ^2,4.

This affects which antibiotics work ^4,8. Antibiotics that target bacterial cell walls do not work against these organisms ^4,8.

*Mycoplasma hominis* differs from *Mycoplasma genitalium*. The names sound similar, but the organisms do not have the same clinical meaning.

*Mycoplasma genitalium* is considered a sexually transmitted infection. It can cause urethritis and has links with cervicitis and pelvic inflammatory disease.

By contrast, *Mycoplasma hominis* appears in healthy people and people with symptoms. Finding it does not establish that it caused the person’s symptoms.

The germ can sometimes cause disease ⁸. It has been reported in genital infections and serious infections elsewhere in the body ⁴.

Reports include brain abscesses and infections in joints, wounds, and kidneys ⁴. But such reports do not mean every positive genital test shows an infection.

The key question is not just whether the germ is there. A clinician must also ask if it explains the person’s illness.

*Mycoplasma hominis* can spread through direct sexual contact. Carriage also occurs in the genital tract of sexually active people.

But under the 2018 European guidance, a routine genital finding is not a standard STI diagnosis. The organism often reflects carriage rather than a disease needing treatment.

This matters because some commercial test panels check for many germs at once. They may check for known STI germs as well as *Mycoplasma hominis*.

A positive result may therefore appear on a broad STI panel. Its location on that panel does not prove that it caused an STI syndrome.

Carriage has been linked with sexual activity and the number of partners ^2,5. Still, a positive result alone cannot tell carriage from active disease.

Other infections must also be considered. Known STI causes may explain symptoms better than *Mycoplasma hominis*.

If you are worried about sexual exposure, ask which infections your tests checked for. The answer may guide whether other tests are appropriate.

Do not assume germs with similar names mean the same thing. Clinicians must view *Mycoplasma hominis* and *Mycoplasma genitalium* differently.

Many people carrying *Mycoplasma hominis* have no symptoms. The organism is also found in people who report genital or urinary symptoms.

This overlap makes symptoms difficult to interpret. Detection in someone with symptoms still does not prove that the organism caused them.

Studies have looked at possible links with urethritis, cystitis, and upper urinary tract infections ⁵. They have also looked at bladder pain and overactive bladder ⁵.

The role of mycoplasma and ureaplasma in bladder pain syndrome and overactive bladder remains controversial ⁵. In many cases, the organism’s role can only be suspected rather than proven ⁵.

Bacterial vaginosis can also confuse the picture in women. This condition involves an altered balance of vaginal bacteria.

Older research often failed to adjust for bacterial vaginosis or related bacteria. That makes many study results hard to judge.

The European guidance says women with symptoms should be tested for bacterial vaginosis. If testing finds bacterial vaginosis, it should be treated.

Symptoms may also have causes not covered by a broad mycoplasma panel. A clinician can review your history and decide what else needs testing.

If symptoms continue, avoid relying on one laboratory result. Persistent symptoms deserve a wider clinical assessment.

A positive result means the lab found *Mycoplasma hominis* in the sample. That sample might come from urine, semen, or a genital swab ³.

The result shows the germ was found where the sample was taken. It cannot, on its own, tell harmless carriage from disease.

The sample site matters. A finding in a genital sample has a different meaning from one in a normally sterile body site.

*Mycoplasma hominis* has caused serious infections outside the genital tract ⁴. Reports include infections involving joints, wounds, heart tissues, and the nervous system ⁴.

Clinicians look at the whole illness and where the sample came from. Genital carriage alone cannot explain findings at another body site.

Test design also matters. Some tests report only whether the germ’s genetic material is there.

These are called qualitative PCR tests. PCR is a method that detects genetic material from an organism.

Some qualitative tests cannot clearly tell mycoplasma or ureaplasma species apart. Poor reporting can add to the confusion.

Culture can also detect these organisms ³. Specialized culture may name the species and test how it responds to antibiotics in the lab ³.

A positive result deserves several basic questions:

These questions help you make sense of the result. A lab finding should not stand alone.

A positive genital result does not prove active infection. It may reflect carriage without illness.

It also does not prove that *Mycoplasma hominis* caused current symptoms. Healthy people and symptomatic people can both test positive.

The result does not establish urethritis, cervicitis, or another STI syndrome by itself. In many adult cases, it is still unclear whether this germ is a direct cause.

A positive result does not mean antibiotics will improve symptoms. The European guidance found no evidence that routine testing and treatment do more good than harm.

It also does not mean every antibiotic will work. *Mycoplasma hominis* has no cell wall, so drugs that target cell walls do not work against it ⁴.

Finding this germ does not take the place of tests for other possible causes. Known STI germs and bacterial vaginosis may need to be considered on their own.

A lab can find a germ correctly without proving it caused disease. This distinction helps you understand *Mycoplasma hominis* results.

In one study, the MYCOPLASMA IST3 culture-based assay identified *Mycoplasma hominis* with 95.7% sensitivity and 100% specificity against reference methods ³. But an accurate test cannot tell if the germ caused symptoms.

A positive result is therefore one piece of evidence. Your symptoms and other findings help show what it means for your health.

Testing methods include PCR and specialized culture ^3,4. Routinely used axenic culture media do not detect the organism ⁴.

PCR looks for *Mycoplasma hominis* genetic material ⁴. A PCR test made for this species aims to tell it apart from other germs ⁴.

Culture tries to grow the germ from a patient sample ³. Some culture tests also gauge how much is there and how it responds to antibiotics in the lab ³.

Samples may include the following types ³:

How the sample is taken can affect the test. Some multiplex tests may have limited sensitivity or specificity.

Sensitivity describes how well a test finds the target when present. Specificity describes how well it avoids positive results when the target is absent.

Some home- or self-collected samples may give less reliable results. So the test and how the sample was taken both matter.

Culture methods also have limits. Some older methods cannot tell ureaplasma species apart.

Poor reporting can mislabel germs or group them together. That can make the result harder to use when deciding on care.

A diagnosis takes more than a lab finding. A clinician must decide if the finding explains the patient’s illness.

For nonpregnant adults, routine testing is not recommended by the 2018 European guidance. This applies even when genital or urinary symptoms are present.

A separate systematic review recommended testing for mycoplasma and ureaplasma when urinary symptoms persist despite negative standard cultures and routine antibiotics ⁵. The advice differs, so some questions remain open.

Routine treatment is not advised for nonpregnant adults without symptoms. The same guidance advises against routine treatment for nonpregnant adults with symptoms.

This recommendation reflects uncertainty about benefit. Genital detection often represents carriage instead of disease.

Unneeded antibiotics can select for antibiotic resistance. This may affect *Mycoplasma hominis*, known STI germs, and other bacteria that normally live in the body.

Unneeded testing and treatment can also create substantial costs. The European statement says these costs may hit women especially hard.

A clinician may still consider treatment if a severe *Mycoplasma hominis* infection outside the genital tract is confirmed. *Mycoplasma hominis* can cause genital and serious infections outside the genital tract ⁴.

Each case needs its own medical review. Treatment should not be chosen from the test name alone.

Drug choice requires care because the organism lacks a cell wall ⁴. Beta-lactam antibiotics target bacterial cell walls and do not work against it ⁴.

Penicillin is an example of a common cell-wall antibiotic ⁸. Do not use leftover medication or another person’s prescription.

Some culture tests can check antibiotic response in the lab ³. Even then, a clinician must weigh the result against the illness.

Before treatment, ask the clinician who prescribes it:

Do not assume every positive result means the germ must be cleared. For many nonpregnant adults, watchful waiting and further review may be better.

The 2018 European statement covered adult men and nonpregnant women. Its main advice should not apply to pregnancy without a review of the person’s case.

*Mycoplasma hominis* and related germs are linked to pregnancy complications. They can also cause infections outside the genital tract in newborns.

The bacterium may pass from a parent to a baby during childbirth ⁸. This concern is noted particularly for premature babies ⁸.

If you are pregnant, discuss a positive result with your maternity clinician. The clinician can weigh your symptoms, pregnancy stage, sample site, and other findings.

Do not start or stop an antibiotic without that review. This evidence does not give one treatment plan for all pregnant people.

People with weakened immune systems also need a review of their own case. Infections outside the genital tract occur especially in people with weakened immune systems and in newborns.

But serious infections have also been reported in people whose immune systems are not suppressed ⁴. The sample site and whole illness still matter in both groups.

If your immune system is suppressed, tell the clinician who ordered the test. Include recent procedures, current medicines, and the reason for testing.

A positive genital test may still show carriage. But a finding from another body site may need a different medical review.

If you do not understand the result, contact the clinician who ordered the test. Ask if it likely shows carriage or a possible infection.

It is also reasonable to seek medical advice if symptoms last. A positive result may not identify the actual cause.

People with ongoing urinary symptoms may need broader assessment. The role of *Mycoplasma hominis* in these conditions remains unclear ⁵.

Women with symptoms should be checked for bacterial vaginosis. Other known STI causes may also need to be considered.

Arrange clinical advice in these situations:

*Mycoplasma hominis* can live in the genital and urinary tracts without causing disease. A positive test often reflects carriage rather than an active infection.

The 2018 European STI Guidelines Editorial Board advises against routine testing and treatment. This recommendation covers symptomatic and asymptomatic nonpregnant adults.

Symptoms and the sample site must also be weighed with a positive result. Other test results and personal risk factors also matter.

The result does not prove that *Mycoplasma hominis* caused symptoms. It also does not show that routine antibiotics will help.

*Mycoplasma hominis* and related germs are associated with pregnancy complications and can cause infections outside the genital tract, especially in people with suppressed immune systems. These cases need more than a quick reading of a genital screening result.